Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challenger

BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challenger

August 3, 2026Posted inBiotechnology

BlossomHill Therapeutics plans to raise $111.7 million to fund the clinical journey of its potential challenger to Tagrisso.

Post navigation

Previous Post
how-the-brain-sustains-motivation How the Brain Sustains Motivation
Next Post
Foundation Model Uses Sleep Data to Predict Health Risks and Clinical Outcomes foundation-model-uses-sleep-data-to-predict-health-risks-and-clinical-outcomes

Recent Posts

  • Virginia Tech leads $9.26 million NIH push to model hormones and women’s health
  • Peer Review Champions Honored in Springer Nature Editor of Distinction Awards 2026
  • New Risk Model Flags Skin Damage Around PICC Lines Before It Strikes
  • Rare Sugar D-Allulose Eases Fatty Liver Damage in Diabetic Mice by Reshaping Gut Microbes and Tryptophan Signaling
  • Tumors Are Not Sterile: How Microbes Living Inside Cancers Reshape Immunity and Immunotherapy

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top